The potential of spectral domain optical coherence tomography imaging based retinal biomarkers.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28078103)

Published in Int J Retina Vitreous on January 09, 2017

Authors

Prateep Phadikar1, Sandeep Saxena1, Surabhi Ruia1, Timothy Y Y Lai2, Carsten H Meyer3, Dean Eliott4

Author Affiliations

1: Department of Ophthalmology, King George's Medical University, Lucknow, U.P. 226003 India.
2: Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Shatin, Hong Kong.
3: Department of Ophthalmology, Pallas Klinik, Aarau, Switzerland.
4: Harvard Medical School, Massachusetts Eye and Ear, Boston, MA USA.

Articles cited by this

THE ENVIRONMENT AND DISEASE: ASSOCIATION OR CAUSATION? Proc R Soc Med (1965) 40.52

Imaging of macular diseases with optical coherence tomography. Ophthalmology (1995) 7.07

Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema. Ophthalmology (2006) 5.79

State-of-the-art retinal optical coherence tomography. Prog Retin Eye Res (2007) 5.37

Choroidal thickness in polypoidal choroidal vasculopathy and exudative age-related macular degeneration. Ophthalmology (2011) 2.49

Oct-based interpretation of the vitreomacular interface and indications for pharmacologic vitreolysis. Retina (2013) 2.49

Optical coherence tomography may be used to predict visual acuity in patients with macular edema. Invest Ophthalmol Vis Sci (2011) 2.45

The International Vitreomacular Traction Study Group classification of vitreomacular adhesion, traction, and macular hole. Ophthalmology (2013) 2.35

Optical coherence tomography-defined changes preceding the development of drusen-associated atrophy in age-related macular degeneration. Ophthalmology (2014) 2.17

Optophysiology: depth-resolved probing of retinal physiology with functional ultrahigh-resolution optical coherence tomography. Proc Natl Acad Sci U S A (2006) 2.05

Vision loss after intravitreal ocriplasmin: correlation of spectral-domain optical coherence tomography and electroretinography. JAMA Ophthalmol (2014) 2.03

Progression of geographic atrophy in age-related macular degeneration imaged with spectral domain optical coherence tomography. Ophthalmology (2010) 1.93

Biomarkers and surrogate end points--the challenge of statistical validation. Nat Rev Clin Oncol (2010) 1.87

Associations between macular findings by optical coherence tomography and visual outcomes after epiretinal membrane removal. Am J Ophthalmol (2008) 1.86

Subfoveal choroidal thickness in typical age-related macular degeneration and polypoidal choroidal vasculopathy. Graefes Arch Clin Exp Ophthalmol (2011) 1.83

What are biomarkers? Curr Opin HIV AIDS (2010) 1.80

Choroidal thickness in patients with diabetic retinopathy analyzed by spectral-domain optical coherence tomography. Retina (2012) 1.79

Macular morphology and visual acuity in the comparison of age-related macular degeneration treatments trials. Ophthalmology (2013) 1.57

Changes of macular and RNFL thicknesses measured by Stratus OCT in patients with early stage diabetes. Eye (Lond) (2008) 1.48

Spectral domain optical coherence tomography imaging of drusen in nonexudative age-related macular degeneration. Ophthalmology (2011) 1.37

Spectral-domain optical coherence tomography for monitoring epiretinal membrane surgery. Ophthalmology (2010) 1.34

Biomarkers and surrogate endpoints. Br J Clin Pharmacol (2005) 1.25

Analysis of morphological features and vascular layers of choroid in diabetic retinopathy using spectral-domain optical coherence tomography. JAMA Ophthalmol (2013) 1.21

Spectral-domain optical coherence tomography measures of outer segment layer progression in patients with X-linked retinitis pigmentosa. JAMA Ophthalmol (2013) 1.20

Measurement of the hemoglobin oxygen saturation level with spectroscopic spectral-domain optical coherence tomography. Opt Lett (2008) 1.19

Guidance for the treatment of neovascular age-related macular degeneration. Acta Ophthalmol Scand (2007) 1.17

The Royal College of Ophthalmologists Guidelines on AMD: Executive Summary. Eye (Lond) (2013) 1.15

Preoperative inner segment/outer segment junction in spectral-domain optical coherence tomography as a prognostic factor in epiretinal membrane surgery. Retina (2011) 1.10

Enhanced depth imaging optical coherence tomography in type 2 diabetes. Invest Ophthalmol Vis Sci (2012) 1.10

Progression of intermediate age-related macular degeneration with proliferation and inner retinal migration of hyperreflective foci. Ophthalmology (2013) 1.06

Quantitative SD-OCT imaging biomarkers as indicators of age-related macular degeneration progression. Invest Ophthalmol Vis Sci (2014) 1.06

The correlation between optical coherence tomographic features and severity of retinopathy, macular thickness and visual acuity in diabetic macular edema. Int Ophthalmol (2006) 1.04

Status of serum VEGF and ICAM-1 and its association with external limiting membrane and inner segment-outer segment junction disruption in type 2 diabetes mellitus. Mol Vis (2013) 0.98

Optical coherence tomography-based observation of the natural history of drusenoid lesion in eyes with dry age-related macular degeneration. Ophthalmology (2013) 0.97

Assessing the photoreceptor mosaic over drusen using adaptive optics and SD-OCT. Ophthalmic Surg Lasers Imaging (2010) 0.97

Pigment epithelial detachment followed by retinal cystoid degeneration leads to vision loss in treatment of neovascular age-related macular degeneration. Ophthalmology (2015) 0.96

Retinal oxygen metabolism in exudative age-related macular degeneration. Acta Ophthalmol (2013) 0.95

Disorganization of the retinal inner layers as a predictor of visual acuity in eyes with center-involved diabetic macular edema. JAMA Ophthalmol (2014) 0.93

Morphological and functional analysis of the loading regimen with intravitreal ranibizumab in neovascular age-related macular degeneration. Br J Ophthalmol (2009) 0.91

Identification of optical density ratios in subretinal fluid as a clinically relevant biomarker in exudative macular disease. Invest Ophthalmol Vis Sci (2009) 0.90

Differential optical density of subretinal spaces. Invest Ophthalmol Vis Sci (2012) 0.90

Predictors of visual outcome in eyes with choroidal neovascularization secondary to age related macular degeneration treated with intravitreal bevacizumab monotherapy. Int J Ophthalmol (2013) 0.89

Parallelism for quantitative image analysis of photoreceptor-retinal pigment epithelium complex alterations in diabetic macular edema. Invest Ophthalmol Vis Sci (2014) 0.89

Change in drusen volume as a novel clinical trial endpoint for the study of complement inhibition in age-related macular degeneration. Ophthalmic Surg Lasers Imaging Retina (2014) 0.89

Spectral domain optical coherence tomography imaging of dry age-related macular degeneration. Ophthalmic Surg Lasers Imaging (2010) 0.89

Intraretinal cysts are the most relevant prognostic biomarker in neovascular age-related macular degeneration independent of the therapeutic strategy. Br J Ophthalmol (2014) 0.88

Morphologic parameters relevant for visual outcome during anti-angiogenic therapy of neovascular age-related macular degeneration. Ophthalmology (2014) 0.88

A quantitative approach to identify morphological features relevant for visual function in ranibizumab therapy of neovascular AMD. Invest Ophthalmol Vis Sci (2014) 0.87

Drusen Volume and Retinal Pigment Epithelium Abnormal Thinning Volume Predict 2-Year Progression of Age-Related Macular Degeneration. Ophthalmology (2015) 0.87

Parallelism as a novel marker for structural integrity of retinal layers in optical coherence tomographic images in eyes with epiretinal membrane. Am J Ophthalmol (2013) 0.86

Change in drusen area over time compared using spectral-domain optical coherence tomography and color fundus imaging. Invest Ophthalmol Vis Sci (2014) 0.85

REFRACTORY INTRARETINAL OR SUBRETINAL FLUID IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION TREATED WITH INTRAVITREAL RANIZUBIMAB: Functional and Structural Outcome. Retina (2015) 0.84

In vivo visualization of photoreceptor layer and lipofuscin accumulation in stargardt's disease and fundus flavimaculatus by high resolution spectral-domain optical coherence tomography. Clin Ophthalmol (2009) 0.83

Nitric oxide and oxidative stress is associated with severity of diabetic retinopathy and retinal structural alterations. Clin Experiment Ophthalmol (2015) 0.83

Integrated photoacoustic ophthalmoscopy and spectral-domain optical coherence tomography. J Vis Exp (2013) 0.83

Optical coherence tomography in the preoperative and postoperative management of macular hole and epiretinal membrane. Br J Ophthalmol (2014) 0.83

Subfoveal choroidal thickness in polypoidal choroidal vasculopathy after switching to intravitreal aflibercept injection. Jpn J Ophthalmol (2015) 0.82

Comparison of drusen area detected by spectral domain optical coherence tomography and color fundus imaging. Invest Ophthalmol Vis Sci (2013) 0.82

Choroidal Thickness Changes in Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy: A 12-Month Prospective Study. Am J Ophthalmol (2015) 0.82

Three-dimensional spectral domain optical coherence tomography in vitreomacular traction. BMJ Case Rep (2014) 0.81

New insights into Stargardt disease with multimodal imaging. Ophthalmic Surg Lasers Imaging Retina (2015) 0.81

Depth-resolved blood oxygen saturation assessment using spectroscopic common-path Fourier domain optical coherence tomography. IEEE Trans Biomed Eng (2010) 0.79

Increased serum urea and creatinine levels correlate with decreased retinal nerve fibre layer thickness in diabetic retinopathy. Biomarkers (2015) 0.79

Noninvasive in vivo imaging of oxygen metabolic rate in the retina. Conf Proc IEEE Eng Med Biol Soc (2014) 0.78

Three-dimensional spectral domain optical coherence tomography in Stargardt disease and fundus flavimaculatus. J Ocul Biol Dis Infor (2012) 0.76

Structure-Function Modeling of Optical Coherence Tomography and Standard Automated Perimetry in the Retina of Patients with Autosomal Dominant Retinitis Pigmentosa. PLoS One (2016) 0.76

Optical density ratio in the subretinal fluid: differentiating chronic central serous chorioretinopathy and polypodial choroidal vasculopathy. Am J Ophthalmol (2014) 0.76

Correlation of biomarkers thiobarbituric acid reactive substance, nitric oxide and central subfield and cube average thickness in diabetic retinopathy: a cross-sectional study. Int J Retina Vitreous (2016) 0.76

Diabetes induces changes in neuroretina before retinal vessels: a spectral-domain optical coherence tomography study. Int J Retina Vitreous (2015) 0.76

Articles by these authors

The natural history of polypoidal choroidal vasculopathy: a multi-center series of untreated Asian patients. Graefes Arch Clin Exp Ophthalmol (2015) 0.82